WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2016

Mar 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2016-03-01

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-01	Common Stock	M	7000.0000	$16.0450	Acquired	70506.9774	Direct
2016-03-01	Common Stock	M	1414.0000	$22.4850	Acquired	71920.9774	Direct
2016-03-01	Common Stock	S	1414.0000	$63.6600	Disposed	70506.9774	Direct
2016-03-01	Common Stock	S	7000.0000	$63.5977	Disposed	63506.9774	Direct
2016-03-01	Common Stock	S	8000.0000	$63.5564	Disposed	55506.9774	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-01	Stock Option (Right to Buy)	$16.0450	M	7000.0000	Disposed	2019-02-24	Common Stock (7000.0000)	Direct
2016-03-01	Stock Option (Right to Buy)	$22.4850	M	1414.0000	Disposed	2018-02-27	Common Stock (1414.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	915.4835	Indirect
Common Stock	7361.8265	Indirect

Footnotes

F1: The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $63.50 to $63.63, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.